Unlocking the access to rare plant-based therapeutic
compounds through biotechnology
AN INNOVATIVE SOLUTION
Embracing the future, STH BIOTECH is committed to ensure that our technology drives a transformative influence on both society and the environment.
SCALABLE
SUSTAINABLE
COST-EFFICIENT
CONSISTENT
STH BIOTECH, A PLANT BIOTECH PIONEER
SEEKING TO TRY NEW DRUGS CANDIDATES ?
Cannabis is a gold mine of therapeutic compounds, with cannabinoids serving as promising treatments to address chronic pain, mental disorders, and neurodegenerative diseases.
Interest directed towards the exploration of minor cannabinoids and alkaloids.
Fueling pharmaceutical innovation, SATIVITRO® can deliver reliable and pure APIs to empower companies in their quest for breakthrough medicines.
OUR CURRENT FOCUS
A UNIQUE PRODUCTION PLATFORM
SOLVING ACCESSIBILITY CHALLENGE
SATIVITRO®
Bioproduction
Unlocking new solutions, we break through the barriers of limited access to plant-based compounds, revolutionizing yields by amplifying the plant's metabolism for a 1000-fold increase in target compounds.
YOUR MOLECULE FOR YOUR APPLICATION
OUR TEAM
Héloïse MAILHAC
Naomi KAMINSKY
Lucas MEDJANI
CEO, Co-founder
CTO, Co-founder
CCO, Partner
HEC entrepreneur & biotech engineer. Head of finance and global strategy
Engineer specialized in plant biotechnology. Inventor
of STH’s technology
Head of business and marketing strategy. Key Account Sales Manager
@Genopole
SUPPORTED BY
Grand Prix 2023